- Home
- TVTX vs LBTYA Comparison
TVTX vs LBTYA Comparison
Compare TVTX & LBTYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVTX
- LBTYA
- Stock Information
- Founded
- TVTX 2008
- LBTYA 2004
- Country
- TVTX United States
- LBTYA Bermuda
- Employees
- TVTX N/A
- LBTYA N/A
- Industry
- TVTX Biotechnology: Pharmaceutical Preparations
- LBTYA Cable & Other Pay Television Services
- Sector
- TVTX Health Care
- LBTYA Telecommunications
- Exchange
- TVTX Nasdaq
- LBTYA Nasdaq
- Market Cap
- TVTX 3.1B
- LBTYA 3.7B
- IPO Year
- TVTX N/A
- LBTYA N/A
- Fundamental
- Price
- TVTX $35.18
- LBTYA $10.67
- Analyst Decision
- TVTX Strong Buy
- LBTYA Buy
- Analyst Count
- TVTX 15
- LBTYA 5
- Target Price
- TVTX $37.21
- LBTYA $14.96
- AVG Volume (30 Days)
- TVTX 2.1M
- LBTYA 2.2M
- Earning Date
- TVTX 10-30-2025
- LBTYA 10-30-2025
- Dividend Yield
- TVTX N/A
- LBTYA N/A
- EPS Growth
- TVTX N/A
- LBTYA N/A
- EPS
- TVTX N/A
- LBTYA N/A
- Revenue
- TVTX $435,826,000.00
- LBTYA $4,770,600,000.00
- Revenue This Year
- TVTX $108.68
- LBTYA $13.25
- Revenue Next Year
- TVTX $40.23
- LBTYA $1.75
- P/E Ratio
- TVTX N/A
- LBTYA N/A
- Revenue Growth
- TVTX 114.22
- LBTYA 170.50
- 52 Week Low
- TVTX $12.91
- LBTYA $9.03
- 52 Week High
- TVTX $36.76
- LBTYA $14.30
- Technical
- Relative Strength Index (RSI)
- TVTX 66.12
- LBTYA 42.75
- Support Level
- TVTX $33.05
- LBTYA $10.52
- Resistance Level
- TVTX $36.76
- LBTYA $11.06
- Average True Range (ATR)
- TVTX 1.95
- LBTYA 0.38
- MACD
- TVTX -0.02
- LBTYA 0.00
- Stochastic Oscillator
- TVTX 80.99
- LBTYA 32.47
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.
About LBTYA Liberty Global Ltd.
Liberty Global is a holding company with interests in European telecom companies in the UK, the Netherlands, Belgium, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.